Park Place Capital’s Privia Health PRVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$41.6K Hold
1,617
0.01% 458
2026
Q1
$33.3K Hold
1,617
0.01% 419
2025
Q4
$38.3K Hold
1,617
0.01% 368
2025
Q3
$40.3K Sell
1,617
-525
-25% -$11.3K 0.01% 365
2025
Q2
$48.3K Hold
2,142
0.01% 355
2025
Q1
$48.1K Buy
2,142
+390
+22% +$9.06K 0.01% 346
2024
Q4
$34.3K Sell
1,752
-64
-4% -$1.27K 0.01% 400
2024
Q3
$33.1K Sell
1,816
-24
-1% -$458 0.01% 426
2024
Q2
$32K Sell
1,840
-652
-26% -$11.6K 0.01% 429
2024
Q1
$48.8K Buy
2,492
+1,335
+115% +$28.2K 0.02% 397
2023
Q4
$26.6K Sell
1,157
-710
-38% -$15.9K 0.01% 489
2023
Q3
$42.9K Hold
1,867
0.01% 495
2023
Q2
$48.7K Buy
1,867
+837
+81% +$22.1K 0.01% 495
2023
Q1
$28.4K Buy
1,030
+122
+13% +$3.22K 0.01% 580
2022
Q4
$21K Buy
+908
New +$25.3K 0.01% 643

Other funds holding PRVA

Park Place Capital's PRVA Position: Q2 2026 in Review

Park Place Capital held its Privia Health (PRVA) position steady in Q2 2026 at 1,617 shares worth $41.6K. The position accounts for 0.01% of the portfolio, ranked #458.

Park Place Capital first reported a position in PRVA in Q4 2022 and has held it in 15 quarters since. The position peaked at $48.8K in Q1 2024. 301 funds tracked by Wall St. Rank hold PRVA as of Q2 2026.

  • Park Place Capital held 1,617 shares of Privia Health worth $41.6K as of Q2 2026.
  • Park Place Capital left its Privia Health share count unchanged in Q2 2026.
  • Privia Health made up 0.01% of Park Place Capital's portfolio in Q2 2026, its #458 holding.
  • Park Place Capital first reported a position in Privia Health in Q4 2022 and has held it in 15 quarters since.
  • Park Place Capital's Privia Health position peaked at $48.8K in Q1 2024.
  • 301 funds tracked by Wall St. Rank held Privia Health as of Q2 2026.

Based on Park Place Capital's 13F filing for Q2 2026, filed 14 Aug 2026.